Last reviewed · How we verify
placebo to loratadine
This is a placebo control, not an active drug, and therefore has no pharmacological mechanism.
At a glance
| Generic name | placebo to loratadine |
|---|---|
| Sponsor | Bayer |
| Modality | Small molecule |
| Phase | FDA-approved |
Mechanism of action
Placebo is an inert substance used as a control in clinical trials to establish the efficacy of loratadine through comparison. It contains no active pharmaceutical ingredient and produces no direct pharmacological effect beyond potential placebo response.
Approved indications
Common side effects
Key clinical trials
- Efficacy and Safety of Subcutaneous Dupilumab for the Treatment of Adult Participants With Chronic Pruritus of Unknown Origin (CPUO) (LIBERTY-CPUO-CHIC) (PHASE3)
- A Study to Evaluate the Safety of Combination Montelukast/Loratadine in Mexican Participants With Allergic Rhinitis (MK-0476A-484) (PHASE3)
- Effect of Loratadine/Montelukast Combination on Congestion in SAR Patients Exposed to Pollen in an EEU (Study P04822) (PHASE3)
- A Multicentre Randomized Controlled Clinical Study on the Chitosan Nanocrystalline Qinteng Huoxue Runji Ointment Therapy for Psoriasis With Blood Stasis Syndrome. (PHASE1)
- Over-the-Counter Antihistamines & Heat Stress (PHASE4)
- Efficacy of TCM Capsules Lian Hua Qing Wen Jiao Nang in Mild COVID-19 Patients (PHASE2, PHASE3)
- Effects of Inhibiting Early Inflammation in Kidney Transplant Patients (PHASE2)
- A Study Comparing the Efficacy of Pataday® Once Daily Relief Extra Strength to Claritin® Tablets 24-Hour in Subjects With Allergic Conjunctivitis (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- placebo to loratadine CI brief — competitive landscape report
- placebo to loratadine updates RSS · CI watch RSS
- Bayer portfolio CI